RELIEF
Summary
Randomised controlled trial of a new relief inhaler in mild asthma:
Determine the clinical effectiveness, cost effectiveness and
acceptability, of replacing short-acting beta agonists (SABA) inhalers, containing Salbutamol,
with inhalers containing ICS/formoterol in patients with asthma treated with low dose inhaled corticosteroid (ICS) maintenance treat-ment.
For more information please click HERE for the full summary.
Sponsor -University of Nottingham
Recruitment End Date - May 2024
Type of Study - Recruiting
RSI Points -CRN model 300, Practice nurse model 400
Practice Involvement
SIV training ~ 2 hours
Display posters/leaflets
Database search or/and opportunistic recruitment.
Eligibility check (variable depending on list size)
Mailout via Docmail
Baseline visit at the practice (CRN support available) (10 min/participant)
12 months face-to-face/telephone visit (CRN support available) (10 min/participant)
Eligibility Criteria
Inclusion
Patients aged 18 and over with a clinical diagnosis of mild Asthma
Treated with low dose ICS
Prescribed 11 or fewer canisters of Salbutamol in the last 12 months
Ability to provide written informed consent
Exclusion
Salbutamol used only to prevent exercise induced asthma.
Other respiratory or non-respiratory diagnosis which will affect the trial interpretation
***To express an interest for the RELIEF study please use the form provided and a member of the team will be in touch***